GoodRx Holdings (GDRX) FCF Margin (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of FCF Margin data on file, last reported at 5.52% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin rose 1159.0% year-over-year to 5.52%; the trailing twelve-month figure through Mar 2026 stood at 15.28% (down 79.0% YoY), and the FY2025 full-year result was 12.22%, down 1083.0% from the prior year.
• FCF Margin fell to 5.52% in Q1 2026, from 9.39% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 62.97% in Q3 2024 to a low of 13.49% in Q2 2024.
• A 5-year average of 17.37% and a median of 17.23% in 2022 frame the typical range for FCF Margin.
• Peak annual rise in FCF Margin reached 5272 bps in 2024, while the deepest fall reached 3646 bps in 2024.
• Tracing GDRX's FCF Margin over 5 years: stood at 17.23% in 2022, then jumped by 68 bps to 29.03% in 2023, then fell by 23 bps to 22.45% in 2024, then tumbled by 58 bps to 9.39% in 2025, then slumped by 41 bps to 5.52% in 2026.
• Business Quant data shows GDRX's FCF Margin at 5.52% in Q1 2026, 9.39% in Q4 2025, and 30.49% in Q3 2025.